• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol. Will COVID-19 be a litmus test for post-Ebola Sub-Saharan Africa?

tetano

Editor, Senior Moderator
J Med Virol. 2020 Mar 20. doi: 10.1002/jmv.25780. [Epub ahead of print]
Will COVID-19 be a litmus test for post-Ebola Sub-Saharan Africa?


Agyeman AA[SUP]1[/SUP], Laar A[SUP]2[/SUP], Ofori-Asenso R[SUP]3,[/SUP][SUP]4[/SUP].

Author information




Abstract

In 2014, the worst outbreak of Ebola virus disease (EVD) emerged in sub-Saharan Africa (SSA) causing fear and panic. The outbreak which started in Guinea quickly moved across to Sierra Leone and Liberia. With an average EVD case fatality rate of around 50% (range 25-90%), there were many casualties, and the number of recorded deaths exceeded 11,300 by June 2016.[SUP]1[/SUP] This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.



KEYWORDS:

Coronavirus; Disease control; Ebolavirus; Virus classification; Virus classificationVirus classificationVirus classification


PMID:32196700DOI:10.1002/jmv.25780
 
Back
Top